Why do influenza virus subtypes die out? A hypothesis

mBio

Volumn 2, Issue 5, 2011, Pages

  Palese, Peter ^a   Wang, Taia T ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; SIALIDASE;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; CROSS REACTION; DISEASE SEVERITY; HUMORAL IMMUNITY; IMMUNOGENICITY; INFLUENZA VIRUS; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H2N2; INFLUENZA VIRUS A H3N2; MEMORY CELL; NONHUMAN; PANDEMIC INFLUENZA; PHYLOGENY; PRIORITY JOURNAL; SEASONAL INFLUENZA; VIRUS GENOME; VIRUS STRAIN;

ORTHOMYXOVIRIDAE;

EID: 80455168614     PISSN: None     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00150-11     Document Type: Article

References (17)

1. Palese P, Shaw ML. 2007. Orthomyxoviridae: the viruses and their replication, p. 1647-1689. In Knipe DM, et al. (ed), Fields virology, vol. 2, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
2. Chen Z, et al. 2000. Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase. Vaccine 18:3214-3222.
3. Sandbulte MR, et al. 2007. Cross-reactive neuraminidase antibodies afford partial protection against H5N1inmice and are present inunexposed humans. PLoS Med. 4:e59.
4. Kilbourne ED, et al. 2004. Protection of mice with recombinant influenza virus neuraminidase. J. Infect. Dis. 189:459-461.
5. Mullooly JP, Barker WH. 1982. Impact of type A influenza on children: a retrospective study. Am. J. Public Health 72:1008-1016.
6. Glezen WP. 1996. Emerging infections: pandemic influenza. Epidemiol. Rev. 18:64-76.
7. Bodewes R, et al. 2011. Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands. Clin. Vaccine Immunol. 18:469-476.
8. Karageorgopoulos DE, Vouloumanou EK, Korbila IP, Kapaskelis A, Falagas ME. 2011. Age distribution of cases of 2009 (H1N1) pandemic influenza in comparison with seasonal influenza. PLoS One 6:e21690.
9. Ekiert DC, et al. 2009. Antibody recognition of a highly conserved influenza virus epitope. Science 324:246-251.
10. Sui J, et al. 2009. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat. Struct. Mol. Biol. 16:265-273.
11. Cox NJ, Subbarao K. 2000. Global epidemiology of influenza: past and present. Annu. Rev. Med. 51:407-421.
12. Epstein SL. 2006. Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature. J. Infect. Dis. 193:49-53.
13. van Reeth K, et al. 2009. Prior infection with an H1N1 swine influenza virus partially protects pigs againstalow pathogenic H5N1 avian influenza virus. Vaccine 27:6330-6339.
14. Kilbourne ED, Christenson WN, Sande M. 1968. Antibody response in man to influenza virus neuraminidase following influenza. J. Virol. 2:761-762.
15. Murphy BR, Kasel JA, Chanock RM. 1972. Association of serum anti-neuraminidase antibody with resistance to influenza in man. N. Engl. J. Med. 286:1329-1332.
16. xu R, et al. 2010. Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science 328:357-360.
17. Wrammert J, et al. 2011. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J. Exp. Med. 208:181-193.